WindebankA, GrisoldW: Chemotherapy-induced neuropathy. J Peripher Nerv Syst, 2008; 13:27–46.
2.
PachmanD, BartonJ, WatsonE, et al.: Chemotherapy-induced peripheral neuropathy: Prevention and treatment. Clin Pharmacol Ther, 2011; 90:377–397.
3.
ArgyriouA, BrunaJ, MarmiroliP, et al.: Chemotherapy-induced peripheral neurotoxicity (CINP): An update. Crit Rev Oncol Hematol, 2012; 82:51–77.
4.
StubblefieldM, BursteinH, BurtonA, et al.: NCCN Task Force Report: Management of neuropathy in cancer. J Natl Compr Canc Netw, 2009; 7:S1–S26.
5.
AlbersJW, ChaundryV, CavalettiG, DonehowerRC: Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev, 2014; 3:CD005228.
6.
DurandJ, DeplanqueG, MontheilV, et al.: Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: Results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Ann Oncol, 2012; 23:200–205.
7.
WasifM, SyrigosK, KaleyD, et al.: Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy. Anticancer Res, 2010; 30:2927–2934.
8.
RaoR, MichalakJ, SloanJ, et al.: Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: A phase 3 randomized, double blind, placebo-controlled, crossover trial (N00C3). Cancer, 2007; 110:2110–2118.
9.
RaoR, FlynnP, SloanJ, et al.: Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy. Cancer, 2008; 112:2802–2808.
10.
HammackJ, MichalakJ, LoprinziC, et al.: Phase III evaluation of nortriptyline for alleviation of symptoms of cisplatinum-induced peripheral neuropathy. Pain, 2002; 98:195–203.
11.
LovoieE, PangH, CirrincioneC, et al.: Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: A randomized clinical trial. JAMA, 2013; 309:1359–1367.
